Citation

Bornheimer LA, Li Verdugo J, Holzworth J, Im V, Smith FN, Sliwa H, Taylor SF, King CA, Florence T, Tarrier N, Himle JA. Psychiatry Res. 2022; 311: e114505.

Copyright

(Copyright © 2022, Elsevier Publishing)

DOI

10.1016/j.psychres.2022.114505

PMID

35290884

PMCID

PMC9373852

Abstract

Suicide is among the leading causes of death for adults with schizophrenia spectrum disorders. Given a paucity of evidence-based interventions tailored for psychosis, we sought to modify a promising Cognitive-Behavioral Suicide Prevention for psychosis (CBSPp) treatment for adults in US community mental health (CMH) settings using community-based participatory research methods. This article presents our modification methodology, stakeholder data and scholarly expert input, and CBSPp adaptations prior to future intervention testing. Stakeholder data (n = 25) were collected from clients, providers, and peer advocates in a CMH setting in Michigan.

FINDINGS were subsequently presented to a panel of scholarly experts in the fields of suicide and psychosis research, intervention research, and implementation science for input. Emerging themes from stakeholders include logistic, perceptual, and clinical challenges in the process of introducing this treatment in a CMH setting. Consistent with literature, buy-in and support for the delivery of a new treatment emerged as important factors in modifying and implementing CBSPp. A final modification list is presented in this paper and collaborations among stakeholders, researchers, and scholarly experts are essential to navigate psychosocial treatment innovation barriers with an overall goal of improving access, feasibility, and quality of this suicide prevention treatment.

Language: en

Keywords

Humans; Adult; Suicide; Cognition; Mental Health; Schizophrenia; Psychosis; Suicide Prevention; Psychotic Disorders; Cognitive behavioral therapy; Community mental health; Community based participatory research; Treatment modification